NOVACYT SIGNS STRATEGIC ALLIANCE WITH CEPHEID FOR HPV DIAGNOSTICS IN LATIN AMERICA

strategic-alliance-agreement-with-cepheid Paris, France and Cambridge, UK – 4th October 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in clinical diagnostics, today announces it has entered into a strategic alliance with Cepheid Inc., a leading international molecular diagnostics company, to introduce a complete Human Papillomavirus (HPV) diagnostic system into Latin America.

Visit Page

NovaPrep to attend 40th European Congress of Cytology in Liverpool in October

NovaPrep will be at Stand 15. 40th European Congress of Cytology 2nd – 5th October 2016 Arena and Convetion Centre Liverpool, England.  

Visit Page